Z-Asp(OtBu)-OSuCAS# 3338-32-7 |
- Fulvestrant
Catalog No.:BCC1081
CAS No.:129453-61-8
- Bazedoxifene
Catalog No.:BCC1411
CAS No.:198481-32-2
- Bazedoxifene acetate
Catalog No.:BCC1412
CAS No.:198481-33-3
- (E)-2-Decenoic acid
Catalog No.:BCC1292
CAS No.:334-49-6
- Toremifene
Catalog No.:BCC2010
CAS No.:89778-26-7
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 3338-32-7 | SDF | Download SDF |
PubChem ID | 102986 | Appearance | Powder |
Formula | C20H24N2O8 | M.Wt | 420.4 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | 4-O-tert-butyl 1-O-(2,5-dioxopyrrolidin-1-yl) 2-(phenylmethoxycarbonylamino)butanedioate | ||
SMILES | CC(C)(C)OC(=O)CC(C(=O)ON1C(=O)CCC1=O)NC(=O)OCC2=CC=CC=C2 | ||
Standard InChIKey | JUMSBOKRGDETHL-UHFFFAOYSA-N | ||
Standard InChI | InChI=1S/C20H24N2O8/c1-20(2,3)29-17(25)11-14(18(26)30-22-15(23)9-10-16(22)24)21-19(27)28-12-13-7-5-4-6-8-13/h4-8,14H,9-12H2,1-3H3,(H,21,27) | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Z-Asp(OtBu)-OSu Dilution Calculator
Z-Asp(OtBu)-OSu Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 2.3787 mL | 11.8934 mL | 23.7869 mL | 47.5737 mL | 59.4672 mL |
5 mM | 0.4757 mL | 2.3787 mL | 4.7574 mL | 9.5147 mL | 11.8934 mL |
10 mM | 0.2379 mL | 1.1893 mL | 2.3787 mL | 4.7574 mL | 5.9467 mL |
50 mM | 0.0476 mL | 0.2379 mL | 0.4757 mL | 0.9515 mL | 1.1893 mL |
100 mM | 0.0238 mL | 0.1189 mL | 0.2379 mL | 0.4757 mL | 0.5947 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
Z-Asp(OtBu)-OSu
- 9-O-Methyl-4-hydroxyboeravinone B
Catalog No.:BCN4063
CAS No.:333798-10-0
- Theaflavine-3,3'-digallate
Catalog No.:BCN5420
CAS No.:33377-72-9
- Gliquidone
Catalog No.:BCC5003
CAS No.:33342-05-1
- Trianthenol
Catalog No.:BCN7802
CAS No.:333361-85-6
- NBD-556
Catalog No.:BCC1790
CAS No.:333353-44-9
- NBD-557
Catalog No.:BCC1791
CAS No.:333352-59-3
- Boc-Phe(4-NO2)-OH
Catalog No.:BCC3275
CAS No.:33305-77-0
- Dipsacoside B
Catalog No.:BCN5940
CAS No.:33289-85-9
- Gummiferin
Catalog No.:BCN8381
CAS No.:33286-30-5
- Diltiazem HCl
Catalog No.:BCC4901
CAS No.:33286-22-5
- 5,6-Dihydroyangonin
Catalog No.:BCN3566
CAS No.:3328-60-7
- 5-Aminofluorescein
Catalog No.:BCC8733
CAS No.:3326-34-9
- 8-Deoxygartanin
Catalog No.:BCN5255
CAS No.:33390-41-9
- Gartanin
Catalog No.:BCN5256
CAS No.:33390-42-0
- LUF 5834
Catalog No.:BCC6237
CAS No.:333962-91-7
- (E)-2-Decenoic acid
Catalog No.:BCC1292
CAS No.:334-49-6
- Spermidine trihydrochloride
Catalog No.:BCC6865
CAS No.:334-50-9
- 3-Hydroxy-3-acetonyloxindole
Catalog No.:BCN4069
CAS No.:33417-17-3
- Etoposide
Catalog No.:BCC1151
CAS No.:33419-42-0
- Quercetin 3,4'-dimethyl ether
Catalog No.:BCN5257
CAS No.:33429-83-3
- 2-Pyridylethylamine dihydrochloride
Catalog No.:BCC7379
CAS No.:3343-39-3
- 3,3'-Bilawsone
Catalog No.:BCN7912
CAS No.:33440-64-1
- Alnustone
Catalog No.:BCN2761
CAS No.:33457-62-4
- Evonine
Catalog No.:BCN3087
CAS No.:33458-82-1
Synthesis, radiolabeling and biological activity of peptide oostatic hormone and its analogues.[Pubmed:9309578]
J Pept Res. 1997 Sep;50(3):153-8.
A series of Pro peptides containing the sequence of the oostatic hormone 3d and its shorter analogues 3a-3c differing in a number of the C-terminal Pro residues was prepared for a study of its effect on oogenesis in Sarcophaga bullata Parker (Diptera). Peptides 3a-3d were synthesized in solution by the fragment condensation of Boc-Tyr-Asp(OtBu)-Pro-Ala-Pro-OH (2f) with Pro oligopeptides H-(Pro)2-5-OtBu. The amino-terminal protected pentapeptide acid 2f was prepared by a stepwise procedure from TFA.H-Ala-Pro-OMe using Boc-Pro-OH, Z-Asp(OtBu)-OSu and Boc-Tyr-OSu. The H(Z)-(Pro)2-5-OtBu oligopeptides 1a-1h were synthesized from Z-Pro-OH and H-Pro-OtBu by a combination of stepwise procedure and fragment condensation. The 125I-labeled molecules of the octapeptide 3b and decapeptide 3d were used for radiotracer distribution studies. Evidence of content of the labeled peptide material in various parts of the insect body (ovaries, head, intestine) is presented. The time distribution of the labeled material in the insect organs was correlated with results of histological analysis of ovaries treated by nonlabeled peptides. The peptides assayed affected processes of egg development in 20-60% of ovarioles. The decapeptide 3d caused changes consisting in some resorbed egg chambers and normal appearance of vitellogenic eggs, whereas the octapeptide 3b caused abnormal yolk deposition and formation of big eggs with irregular yolk granules, proliferation of follicular epithelium in some egg chambers and about the same amount of resorbed egg chambers as decapeptide. These structural differences are complementary to the different values of organ radioactivities.